Showing results (261-270 of 282) with videos related to
Sort By:
Pageof 29
Gut|December 18, 2019
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitisMaren H Harms, Rozanne C de Veer, Willem J Lammers, et al.Journal of Pediatric Gastroenterology and Nutrition|January 18, 2011
Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver diseaseChristine Carter-Kent, Elizabeth M Brunt, Lisa M Yerian, et al.The American Journal of Gastroenterology|December 13, 2017
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and OutcomeMaren H Harms, Willem J Lammers, Douglas Thorburn, et al.Journal of Hepatology|December 3, 2014
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standardsJérôme Boursier, Victor de Ledinghen, Thierry Poynard, et al.Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary CholangitisNikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, et al.Alimentary Pharmacology & Therapeutics|October 18, 2019
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment responseCarla F Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, et al.Hepatology (Baltimore, Md.)|March 30, 2007
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDPaul Angulo, Jason M Hui, Giulio Marchesini, et al.Plos Medicine|July 23, 2014
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisGiovanni Musso, Roberto Gambino, James H Tabibian, et al.Gastroenterology|August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up studyWillem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.Pageof 29